Volume 11, Number 3—March 2005
Research
Ebola Virus Antibody Prevalence in Dogs and Human Risk
Loïs Allela*, Olivier Bourry*, Régis Pouillot†, André Délicat*, Philippe Yaba*, Brice Kumulungui*, Pierre Rouquet*, Jean-Paul Gonzalez‡, and Eric M. Leroy*‡
Table 1
Results of testing pet dogs for Ebola-specific immunoglobulin G antibodies by location
| Location | No. dogs tested | No. dogs positive |
|---|---|---|
| Mekambo/Ekata | ||
| Ekata | 38 | 10 |
| Ilahounene | 15 | 1 |
| Mendemba | 3 | 1 |
| Ntolo | 11 | 3 |
| Mekouma | 12 | 1 |
| Malassa | 5 | 0 |
| Mbeza | 13 | 6 |
| Total | 97 | 22 |
| Mekambo/Mazingo | ||
| Mazingo | 5 | 1 |
| Massombo | 1 | 0 |
| Ego poma | 4 | 1 |
| Grand Etoumbi | 7 | 3 |
| Zoula | 15 | 3 |
| Ibea | 12 | 3 |
| Imbong | 10 | 4 |
| Etakangaye | 8 | 3 |
| Total | 62 | 18 |
| Mekambo | 99 | 15 |
| Libreville | 50 | 5 |
| Port Gentil | 29 | 2 |
| France | 102 | 2 |
| Total | 439 | 64 |
¹Loïs Allela and Olivier Bourry contributed equally to this work.
Page created: April 25, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.